Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 1;9(21):1880-1.
doi: 10.4103/1673-5374.145349.

Neuroactive alkaloids that modulate the neuronal nicotinic receptor and provide neuroprotection in an Alzheimer's disease model: the case of Teline monspessulana

Jorge Fuentealba  1 , Francisco Saez-Orellana  1
Affiliations

Neuroactive alkaloids that modulate the neuronal nicotinic receptor and provide neuroprotection in an Alzheimer's disease model: the case of Teline monspessulana

Jorge Fuentealba et al. Neural Regen Res. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Galanthus nivalis, the plant from where galantamine was first isolated, showing its characteristic flower. (B) Chemical structure of Galantamine. (C) Teline monspessulana the source of TM extract. Note its characteristic yellow flowers and fruit which accumulate quinozilinidinic alkaloids. (D) The chemical structures of quinozilidine and (-)-cytisine, one of the most common quinozilinidinic derivatives.
Figure 2
Figure 2
Schematic representation of the action of alkaloids with potential cholinergic effects in Alzheimer's disease. These alkaloids can modulate acetyl- and/or butyrylcholinesterase (AChE/BuChE) and can also allosterically modulate nAChR, like α7 (central structure in the figure), and promote the activation of the AKT pathway and neuroprotection.
See this image and copyright information in PMC

References

    1. Araya JA, Ramírez AE, Figueroa-Aroca D, Sotes GJ, Pérez C, Becerra J, Saez-Orellana F, Guzmán L, Aguayo LG, Fuentealba J. Modulation of neuronal nicotinic receptor by quinolizidine alkaloids causes neuroprotection on a cellular Alzheimer model. J Alzheimers Dis. 2014;42:143–155. - PubMed
    1. Behl P, Bocti C, Swartz RH, Gao F, Sahlos DJ, Lanctot KL, Streiner Dl, Black SE. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated alzheimer patients. Arch Neurol. 2007;64:266–272. - PubMed
    1. Fuentealba J, Gandia L. La sinapsis colinérgica. In: La huella, nicotínica de la demencia, Garcia A., editors. Madrid, Spain: Infarmex SL; 2006. pp. 1–12.
    1. Fuentealba J, Guzmán L, Manríquez-Navarro P, Pérez C, Silva M, Becerra J, Aguayo LG. Inhibitory effects of tutin on glycine receptors in spinal neurons. Eur J Pharmacol. 2007;559:61–64. - PubMed
    1. Fuentealba J, Muñoz B, Yévenes G, Moraga-Cid G, Pérez C, Guzmán L, Rigo JM, Aguayo LG. Potentiation and inhibition of glycine receptors by tutin. Neuropharmacology. 2011;60:453–459. - PubMed

LinkOut - more resources